416 related articles for article (PubMed ID: 35654458)
1. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
Gwinnutt JM; Wieczorek M; Rodríguez-Carrio J; Balanescu A; Bischoff-Ferrari HA; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda M; Guillemin F; Verstappen SMM
RMD Open; 2022 Jun; 8(2):. PubMed ID: 35654458
[TBL] [Abstract][Full Text] [Related]
2. Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
Gwinnutt JM; Wieczorek M; Cavalli G; Balanescu A; Bischoff-Ferrari HA; Boonen A; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Rodríguez-Carrio J; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda MI; Guillemin F; Verstappen SMM
RMD Open; 2022 Mar; 8(1):. PubMed ID: 35361692
[TBL] [Abstract][Full Text] [Related]
3. Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
Wieczorek M; Gwinnutt JM; Ransay-Colle M; Balanescu A; Bischoff-Ferrari H; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Rodríguez-Carrio J; Silva-Fernández L; Stamm TA; Walker-Bone K; Welling J; Zlatkovic-Svenda M; Verstappen SM; Guillemin F
RMD Open; 2022 Mar; 8(1):. PubMed ID: 35351808
[TBL] [Abstract][Full Text] [Related]
4. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases.
Gwinnutt JM; Wieczorek M; Balanescu A; Bischoff-Ferrari HA; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Rodríguez-Carrio J; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda MI; Guillemin F; Verstappen SMM
Ann Rheum Dis; 2023 Jan; 82(1):48-56. PubMed ID: 35260387
[TBL] [Abstract][Full Text] [Related]
5. Association of vocational interventions and work-related factors with disease and work outcomes in people with RMDs: A systematic review.
Wieczorek M; Verstappen SM; Putrik P; Gwinnutt JM; Balanescu A; Bischoff-Ferrari HA; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Rodríguez-Carrio J; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda M; Guillemin F
Semin Arthritis Rheum; 2023 Feb; 58():152135. PubMed ID: 36434893
[TBL] [Abstract][Full Text] [Related]
6. Developing a framework for the implementation of recommendations for lifestyle factors for people with RMDs across Europe: assessment of current materials and implementation needs.
Rodríguez-Carrio J; Cavalli G; Gwinnutt J; Wieczorek M; Guillemin F; Verstappen SMM
RMD Open; 2023 Aug; 9(3):. PubMed ID: 37652556
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Santos EJF; Farisogullari B; Dures E; Geenen R; Machado PM;
RMD Open; 2023 Aug; 9(3):. PubMed ID: 37604639
[TBL] [Abstract][Full Text] [Related]
8. Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations.
Kedra J; Radstake T; Pandit A; Baraliakos X; Berenbaum F; Finckh A; Fautrel B; Stamm TA; Gomez-Cabrero D; Pristipino C; Choquet R; Servy H; Stones S; Burmester G; Gossec L
RMD Open; 2019; 5(2):e001004. PubMed ID: 31413871
[TBL] [Abstract][Full Text] [Related]
9. Living with foot and ankle disorders in rheumatic and musculoskeletal diseases: A systematic review of qualitative studies to inform the work of the OMERACT Foot and Ankle Working Group.
Chapman LS; Flurey CA; Redmond AC; Richards P; Hofstetter C; Tapster B; Emmel J; Helliwell PS; Menz HB; Hannan MT; Shea B; Siddle HJ
Semin Arthritis Rheum; 2023 Aug; 61():152212. PubMed ID: 37207417
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1).
Garrido-Cumbrera M; Marzo-Ortega H; Christen L; Plazuelo-Ramos P; Webb D; Jacklin C; Irwin S; Grange L; Makri S; Frazão Mateus E; Mingolla S; Antonopoulou K; Sanz-Gómez S; Correa-Fernández J; Carmona L; Navarro-Compán V
RMD Open; 2021 Apr; 7(1):. PubMed ID: 33827969
[TBL] [Abstract][Full Text] [Related]
12. 2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work.
Boonen A; Webers C; Butink M; Barten B; Betteridge N; Black DC; Bremander A; Boteva B; Brzezińska O; Chauhan L; Copsey S; Guimarães V; Gignac M; Glaysher J; Green F; Hoving JL; Marques ML; Smucrova H; Stamm TA; Wiek D; Wilkie R; Woolf AD; Burmester GR; Bijlsma JW; Verstappen SMM
Ann Rheum Dis; 2023 Jan; 82(1):57-64. PubMed ID: 36109139
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Farisogullari B; Santos EJF; Dures E; Geenen R; Machado PM; ;
RMD Open; 2023 Dec; 9(4):. PubMed ID: 38056919
[TBL] [Abstract][Full Text] [Related]
14. 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Dures E; Farisoğulları B; Santos EJF; Molto A; Feldthusen C; Harris C; Elling-Audersch C; Connolly D; Elefante E; Estévez-López F; Bini I; Primdahl J; Hoeper K; Urban M; van de Laar MAFJ; Redondo M; Böhm P; Amarnani R; Hayward R; Geenen R; Rednic S; Pettersson S; Thomsen T; Uhlig T; Ritschl V; Machado PM
Ann Rheum Dis; 2023 Nov; ():. PubMed ID: 38050029
[TBL] [Abstract][Full Text] [Related]
15. Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.
Rodríguez-Carrio J; Burska A; Conaghan PG; Dik WA; Biesen R; Eloranta ML; Cavalli G; Visser M; Boumpas DT; Bertsias G; Wahren-Herlenius M; Rehwinkel J; Frémond ML; Crow MK; Ronnblom L; Vital E; Versnel M
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36882218
[TBL] [Abstract][Full Text] [Related]
16. Trends for opioid prescribing and the impact of the COVID-19 pandemic in patients with rheumatic and musculoskeletal diseases between 2006 and 2021.
Huang YT; Jenkins DA; Yimer BB; Benitez-Aurioles J; Peek N; Lunt M; Dixon WG; Jani M
Rheumatology (Oxford); 2024 Apr; 63(4):1093-1103. PubMed ID: 37432340
[TBL] [Abstract][Full Text] [Related]
17. The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches.
Simões D; Araújo FA; Monjardino T; Severo M; Cruz I; Carmona L; Lucas R
Rheumatol Int; 2018 May; 38(5):905-915. PubMed ID: 29423535
[TBL] [Abstract][Full Text] [Related]
18. Genetic Influence on Osteoarthritis Versus Other Rheumatic Diseases.
Magnusson K; Turkiewicz A; Rydén M; Englund M
Arthritis Rheumatol; 2024 Feb; 76(2):206-215. PubMed ID: 37691153
[TBL] [Abstract][Full Text] [Related]
19. Diet in Rheumatoid Arthritis versus Systemic Lupus Erythematosus: Any Differences?
Alunno A; Carubbi F; Bartoloni E; Grassi D; Ferri C; Gerli R
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33673487
[TBL] [Abstract][Full Text] [Related]
20. Socio-economic inequalities in occurrence and health care costs in rheumatic and musculoskeletal diseases: results from a Spanish population-based study including 1.9 million persons.
Putrik P; Ramiro S; Orueta JF; Keszei A; Alonso Moran E; Nuño Solinis R; Boonen A
Clin Exp Rheumatol; 2018; 36(4):589-594. PubMed ID: 29465359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
